FTC Investigating CVS Caremark Business Practices
Executive Summary
A campaign orchestrated by the National Community Pharmacists Association to have the Federal Trade Commission investigate the business practices of CVS Caremark has borne fruit: the company says it is under investigation
You may also be interested in...
CVS Caremark To Pay FTC $5 Million To Resolve First Medicare Part D Deceptive Pricing Case
The Federal Trade Commission claims a CVS subsidiary posted prices for Rx drugs at CVS and Walgreens pharmacies that were as much as ten times less than the actual prices, pushing consumers into the donut hole more quickly.
CVS Caremark CEO Merlo Dispels Talk Of Company Breakup
Despite lagging performance, Merlo says PBM poised for healthy financial performance in 2012.
Rep. Lynch Pushes PBM Transparency Bill For Federal Benefits; OPM Resists
Congressional efforts to mandate transparency rules for pharmacy benefit managers working in the Federal Employees Health Benefits Program are meeting with some resistance from top officials at the Office of Personnel Management, the agency that oversees FEHBP